Salvinorin A has been investigated for the basic science of Pharmaceutical Preparations.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Salvinorin A. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Salvinorin A. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Salvinorin A. |
| Hydrocodone | Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Salvinorin A. |
| Magnesium sulfate | The therapeutic efficacy of Salvinorin A can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Salvinorin A may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Salvinorin A. |
| Mirtazapine | Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Salvinorin A. |
| Orphenadrine | Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Salvinorin A. |
| Pramipexole | Salvinorin A may increase the sedative activities of Pramipexole. |
| Ropinirole | Salvinorin A may increase the sedative activities of Ropinirole. |
| Rotigotine | Salvinorin A may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Salvinorin A. |
| Sodium oxybate | Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Salvinorin A. |
| Thalidomide | Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Salvinorin A. |
| Ethanol | Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Salvinorin A may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Salvinorin A. |
| Zimelidine | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Salvinorin A. |
| Indalpine | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Alaproclate. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Salvinorin A. |
| Gallamine triethiodide | The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Salvinorin A. |
| Rocuronium | The risk or severity of CNS depression can be increased when Rocuronium is combined with Salvinorin A. |
| Scopolamine | The risk or severity of CNS depression can be increased when Scopolamine is combined with Salvinorin A. |
| Clidinium | The risk or severity of CNS depression can be increased when Clidinium is combined with Salvinorin A. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Salvinorin A. |
| Brompheniramine | The risk or severity of CNS depression can be increased when Brompheniramine is combined with Salvinorin A. |
| Promethazine | The risk or severity of CNS depression can be increased when Promethazine is combined with Salvinorin A. |
| Diphenhydramine | The risk or severity of CNS depression can be increased when Diphenhydramine is combined with Salvinorin A. |
| Doxacurium | The risk or severity of CNS depression can be increased when Doxacurium is combined with Salvinorin A. |
| Mivacurium | The risk or severity of CNS depression can be increased when Mivacurium is combined with Salvinorin A. |
| Metocurine | The risk or severity of CNS depression can be increased when Metocurine is combined with Salvinorin A. |
| Pancuronium | The risk or severity of CNS depression can be increased when Pancuronium is combined with Salvinorin A. |
| Pipecuronium | The risk or severity of CNS depression can be increased when Pipecuronium is combined with Salvinorin A. |
| Rapacuronium | The risk or severity of CNS depression can be increased when Rapacuronium is combined with Salvinorin A. |
| Emepronium | The risk or severity of CNS depression can be increased when Salvinorin A is combined with Emepronium. |
| Zopiclone | The risk or severity of adverse effects can be increased when Salvinorin A is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Salvinorin A. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Salvinorin A. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Salvinorin A. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Salvinorin A. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Salvinorin A. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Salvinorin A. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Salvinorin A. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Salvinorin A. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Salvinorin A. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Salvinorin A. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Salvinorin A. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Salvinorin A. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Salvinorin A. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Salvinorin A. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Salvinorin A. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Salvinorin A. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Salvinorin A. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Salvinorin A. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Salvinorin A. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Salvinorin A. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Salvinorin A. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Salvinorin A. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Salvinorin A. |
| Cetirizine | The risk or severity of CNS depression can be increased when Cetirizine is combined with Salvinorin A. |
| Trimethadione | The risk or severity of CNS depression can be increased when Trimethadione is combined with Salvinorin A. |
| Chlorzoxazone | The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Salvinorin A. |
| Thiethylperazine | The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Salvinorin A. |
| Palonosetron | The risk or severity of CNS depression can be increased when Palonosetron is combined with Salvinorin A. |
| Dexbrompheniramine | The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Salvinorin A. |
| Metocurine iodide | The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Salvinorin A. |
| Secobarbital | The risk or severity of CNS depression can be increased when Secobarbital is combined with Salvinorin A. |
| Methocarbamol | The risk or severity of CNS depression can be increased when Methocarbamol is combined with Salvinorin A. |
| Triprolidine | The risk or severity of CNS depression can be increased when Triprolidine is combined with Salvinorin A. |
| Meperidine | The risk or severity of CNS depression can be increased when Meperidine is combined with Salvinorin A. |
| Metharbital | The risk or severity of CNS depression can be increased when Metharbital is combined with Salvinorin A. |
| Quinine | The risk or severity of CNS depression can be increased when Quinine is combined with Salvinorin A. |
| Methohexital | The risk or severity of CNS depression can be increased when Methohexital is combined with Salvinorin A. |